about
Myocardial bridging: contemporary understanding of pathophysiology with implications for diagnostic and therapeutic strategiesQuantification of the focal progression of coronary atherosclerosis through automated co-registration of virtual histology-intravascular ultrasound imaging data.Thrombocytopenia is an independent predictor of mortality in pulmonary hypertension.Thrombocytopaenia as a Prognostic Indicator in Heart Failure with Reduced Ejection Fraction.Paradoxical emboli through the patent foramen ovale as the suspected cause of myocardial and renal infarction in a 48-year-old woman.Elevated Levels of Serum Fibrin and Fibrinogen Degradation Products Are Independent Predictors of Larger Coronary Plaques and Greater Plaque Necrotic Core.Comprehensive Assessment of Coronary Plaque Progression With Advanced Intravascular Imaging, Physiological Measures, and Wall Shear Stress: A Pilot Double-Blinded Randomized Controlled Clinical Trial of Nebivolol Versus Atenolol in Nonobstructive CoSimultaneous subacute coronary drug-eluting stent thrombosis in two different vessels of a patient with factor V Leiden mutation.Patent foramen ovale and neurosurgery in sitting position: a systematic review.Contemporary clinical applications of coronary intravascular ultrasound.Coronary artery wall shear stress is associated with progression and transformation of atherosclerotic plaque and arterial remodeling in patients with coronary artery disease.Transcranial Doppler: Does Addition of Blood to Agitated Saline Affect Sensitivity for Detecting Cardiac Right-to-Left Shunt?Novel biomarkers of coronary microvascular disease.High wall shear stress and high-risk plaque: an emerging concept.Comparison of angiographic and IVUS derived coronary geometric reconstructions for evaluation of the association of hemodynamics with coronary artery disease progression.Prognostic Significance of Nonobstructive Left Main Coronary Artery Disease in Women Versus Men: Long-Term Outcomes From the CONFIRM (Coronary CT Angiography Evaluation For Clinical Outcomes: An International Multicenter) Registry.Addition of angiotensin-converting enzyme inhibitors to beta-blockers has a distinct effect on hispanics compared with african americans and whites with heart failure and reduced ejection fraction: a propensity score-matching study.Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation.Platypnea-Orthodeoxia Syndrome: From Gastroesophageal Reflux to Hypoxemia.Fractional flow reserve for the assessment of complex multivessel disease in a patient after hybrid coronary revascularization.Localization of culprit lesions in coronary arteries of patients with ST-segment elevation myocardial infarctions: relation to bifurcations and curvatures.Iatrogenic left main coronary artery dissection: incidence, classification, management, and long-term follow-up.Combination of plaque burden, wall shear stress, and plaque phenotype has incremental value for prediction of coronary atherosclerotic plaque progression and vulnerability.Focal association between wall shear stress and clinical coronary artery disease progression.Coronary collateral function in the transplanted heart: propensity score matching with coronary artery disease.Statin therapy improves survival in patients with severe pulmonary hypertension: a propensity score matching study.Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease.Oscillatory wall shear stress is a dominant flow characteristic affecting lesion progression patterns and plaque vulnerability in patients with coronary artery disease.Cardiac shock wave therapy for chronic refractory angina pectoris. A prospective placebo-controlled randomized trial.A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.Transcatheter Patent Foramen Ovale Closure After Cryptogenic Stroke: An Updated Meta-Analysis of Randomized Trials.Protective or destructive: High wall shear stress and atherosclerosis.SPECT perfusion imaging and myocardial bridges: bridging the gap of diagnostic uncertainty.Discordance Between Fractional Flow Reserve and Coronary Flow Reserve: Insights From Intracoronary Imaging and Physiological Assessment.Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantationLow Coronary Wall Shear Stress Is Associated With Severe Endothelial Dysfunction in Patients With Nonobstructive Coronary Artery DiseaseIntimal Thickening Sourced From Low Wall Shear Stress in Human Left Coronary Artery Was Observed by Optical Coherence TomographyIntravascular ultrasound for assessment of coronary drug-eluting stent deployment: an evolving field in need of new criteriaPercutaneous closure of a postinfarction ventricular septal defect and an iatrogenic left ventricular free-wall perforation using two Amplatzer muscular VSD occluders
P50
Q27012712-836A6EE4-AABC-4F5C-B428-4C4C1A77AD78Q31142337-7C1B2F9F-1910-44A2-B3CB-FCE68F8889C0Q33417387-E99BA976-949D-4EC6-ADCC-2851FE845524Q33429937-D4677AB4-1F70-4168-8DD1-2F114367938FQ36847216-FA716D1E-3B0B-4069-8F0F-D046C6DFFDC6Q36872650-5DA90F7C-602F-43AB-97EC-7C739D0732CDQ36877809-C7C37ABB-87A2-48DF-881D-C89E989213A4Q37107839-360DEA80-0D91-4363-9BFD-0A676B20538DQ37433449-0D1E60C8-FF39-485D-BBB1-E6453C3E93F4Q37960682-5983A531-7C25-435C-9B42-D5EEA281987EQ38487404-E1F66955-8B1F-4F83-896E-B28A3A3361B9Q38812502-C65468E3-552B-4021-B88D-D4B36D14FA8EQ38854433-F8A34764-EC8D-4F75-8F7E-693052FB972EQ39027912-20B2710E-EBB0-4CA2-AB68-CC43FE1ABA26Q39733591-910B2DCB-121D-430C-95A3-01515AD58D5EQ40090120-AC52F7FD-2371-4B6A-BDFC-5D8850D549BDQ41169021-30335DBB-840E-424A-ACED-9B4851B59BBAQ42471270-75D4EC66-C349-41CD-8824-2163E81BD4C6Q43077318-69F99EAC-9E04-4DDB-B3AD-98F394B4EDB3Q43446912-F603FAA4-D51D-4B55-99AB-3E2E004DAC6BQ44572555-83EE482C-C3E6-426B-ACA3-2656802A76EFQ44840251-0880FE00-48C5-490D-9D55-3DCC541CEF03Q45087133-4301C0E6-5E35-478D-904A-E36862A3D89CQ45792910-2F6B4048-0C6F-4A13-9BF6-73716A5E82F5Q46043251-6564EF99-BABA-46DB-B48F-C8490C993BEEQ46898193-82DFCA01-CEED-4C21-BD3E-FFC15DE3B0A3Q48112952-D9371E6E-8203-4C15-850E-47BB62771512Q48122593-78C6613A-8DBF-493B-8CF6-B401F79C7C1CQ48287000-4BB67B82-B4C0-4457-8405-23729BB5826BQ48391538-A92E57CF-DDE6-42D4-B098-B1593AE0652AQ49865314-22DD96E5-68CA-46DC-8D3F-DC8EA8965BECQ50087655-8ADAABAF-9408-47BD-9232-FE70431DC6ECQ51297947-998C5C18-EF27-4CE0-BD75-4C04F1D760A2Q53207945-C24B4C71-128B-40D1-85D0-21756578B716Q53739615-96000952-5E92-4220-A293-19BD333BBA0FQ57643930-6787B26B-DB09-4744-8A82-47B4E0964892Q57804315-5A55E88C-020A-4D81-A12C-3C76619EA131Q64355511-200EE868-91E5-4C8C-8D27-6F3EEE991A25Q83365256-C9C5E69E-A2F1-4662-A5C8-C4F5A5BF2555Q83750419-B5B1484F-782D-42C5-BAA4-EBD34C137EB5
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Parham Eshtehardi
@ast
Parham Eshtehardi
@en
Parham Eshtehardi
@es
Parham Eshtehardi
@sl
type
label
Parham Eshtehardi
@ast
Parham Eshtehardi
@en
Parham Eshtehardi
@es
Parham Eshtehardi
@sl
prefLabel
Parham Eshtehardi
@ast
Parham Eshtehardi
@en
Parham Eshtehardi
@es
Parham Eshtehardi
@sl
P1053
F-6582-2011
P106
P1153
24173133800
P31
P3829
P496
0000-0001-8134-1787